Results for tag: "Pancreatic Endocrine Tumor Drug"

The Pancreatic Endocrine Tumor Drug market is a subset of the larger Pancreatic Cancer Drugs market. It is composed of drugs used to treat pancreatic endocrine tumors, which are rare tumors that originate in the endocrine cells of the pancreas. These drugs are used to reduce tumor size, slow tumor growth, and improve symptoms. Commonly used drugs include somatostatin analogs, interferon alfa, and everolimus. The Pancreatic Endocrine Tumor Drug market is highly competitive, with many companies developing and marketing drugs for this indication. Some of the major players in the market include Novartis, Pfizer, Merck, Eli Lilly, and Bristol-Myers Squibb. Show Less Read more